Meta Platforms To $200? These Analysts Slash Price Targets On Meta Following Q3 Results Meta Platforms, Inc. (NASDAQ: META) reported worse-than-expected Q3 EPS and issued Q4 revenue guidance with a midpoint below estimates. The company also guided FY23 expenses of $96 billion to $101 billion. Meta Platforms shares dropped 22.1% to $101.20 on Thursday. Benzinga · Oct 27, 2022
Alphabet To $145? These Analysts Cut Price Targets On Alphabet After Downbeat Q3 Results Alphabet Inc. (NASDAQ: GOOGL) reported weaker-than-expected earnings results for its third quarter after the closing bell on Tuesday. Benzinga · Oct 26, 2022
This Is What Whales Are Betting On Lululemon Athletica Someone with a lot of money to spend has taken a bullish stance on Lululemon Athletica (NASDAQ:LULU). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga. Benzinga · Sep 22, 2022
Why Nuwellis Surged Over 121%; Here Are 66 Biggest Movers From Yesterday Gainers Benzinga · Sep 1, 2022
Why Express Is Trading Higher By Over 21%, Here Are 54 Stocks Moving In Wednesday's Mid-Day Session Gainers Nuwellis, Inc. (NASDAQ: NUWE) shares jumped 140% to $1.5894 after the company announced new clinical data demonstrating 100% survival at 30 days following the use of ultrafiltration in high-risk postoperative coronary artery bypass grafting patients. Benzinga · Aug 31, 2022
Salesforce Faces Price Target Cuts On Guidance Cut, Shares Slide Salesforce Inc (NYSE: CRM) reported upbeat results for its second quarter, but lowered its annual projections. Benzinga · Aug 25, 2022
Pioneers In The Cannabis Industry: Meet Senior Analyst Vivien Azer At Benzinga's Cannabis Capital Conference In Chicago In times of regulatory uncertainty, inflation and stock market volatility, defining an investment strategy can be a wicked problem. Estimating the future of how cannabis stocks can profit from market trends requires experience, a holistic perspective, good information and an extensive network of personal relationships in the industry. Benzinga · Jun 30, 2022
Benzinga · May 25, 2022 Benzinga's Top Ratings Upgrades, Downgrades For May 25, 2022 Upgrades Credit Suisse upgraded the previous rating for Molecular Partners AG (NASDAQ:MOLN) from Underperform to Neutral. NoneAt the moment, the stock has a 52-week-high of $32.04 and a 52-week-low of $5.92. Molecular Partners closed at $6.88 at the end of the last trading period.
Benzinga · May 6, 2022 Amazon.com Whale Trades Spotted Someone with a lot of money to spend has taken a bearish stance on Amazon.com (NASDAQ:AMZN). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.